Full Text
Cost-Effectiveness Analysis of Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer in Portugal

Abstract

Authors

P Saramago M Ines F Saraiva

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×